Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Biogen Idec submits BLA to FDA for Plegridy in multiple sclerosis

May 22, 2013

FDA advisory committee sets date to review MoxDuo NDA

May 21, 2013

Novel cannabinoid CB2 receptor agonists synthesized at Roche

May 21, 2013

XenoPort ends development of arbaclofen placarbil for MS spasticity

May 21, 2013

Helsinn and Vifor sign agreement for netupitant/palonosetron fixed-dose combination

May 21, 2013

Roche prepares new CB2 receptor agonists

May 17, 2013

Merck & Co. prepares novel orexin receptor antagonists

May 17, 2013

A novel mGlur5PV-/- mouse model of schizophrenia shows altered sensorimotor gating

May 17, 2013

NewVac patents novel A2A receptor antagonists

May 16, 2013

Merck & Co. patents novel OX2 receptor antagonists

May 16, 2013

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...